News

Plant and animal cells are both extremely important to the survival of millions of species and without them, life couldn’t exist. Although they share a lot of similarities, they have quite a few ...
And so with allogeneic CAR T-cell therapy, we need to be sure that those donor T cells aren't rejected by the patient's body and also that those donor T cells don't cause graft-vs-host disease ...
The case for fuel cells Fuel cells offer a compelling alternative to EVs by eliminating the dependence on batteries. This means fewer mining-related dependencies and the scope-2 emissions related ...
Stem cell therapy updates medical practices by creating new ways to treat orthopedic problems and health degenerations. Patients confront the largest problem when considering treatment-associated ...
When we use healthy donor cells, we can give them almost right away because we've already have them premade. There's a huge advantage to using allogeneic CAR T cells vs autologous CAR T cells.
Lisocabtagene maraleucel shows superior 3-year outcomes over standard care in second-line large B-cell lymphoma.
With approximately 1.4 GW of BE’s Energy Server systems deployed in more than 1,000 locations and nine countries, its fuel cell platform empowers businesses, essential services, critical ...
High levels of donor-derived cell-free DNA may identify biopsy-proven rejection risk for transplant recipients, according to ...
July 28, 2025 — 10:53 am EDT Written by Avisekh Bhattacharjee for Zacks -> Plug Power Inc. PLUG and FuelCell Energy, Inc. FCEL are both prominent names operating in the fuel cell technology market.
Patients with local or regional cutaneous squamous cell carcinoma are randomly assigned to receive cemiplimab or placebo post ...